Niu, F.-W., Zhang, Y.-J., Li, K., & Zhang, M.-S. (2014). Nobiletin acts as a potential anticancer agent against osteosarcoma by regulating ERK and AKT signaling pathways. Bangladesh Journal of Pharmacology, 9(3), 406–412. https://doi.org/10.3329/bjp.v9i3.19567